Implantable IVC Sensor for Heart Failure Monitoring
Implantable IVC Sensor for Heart Failure Monitoring
Published in: JACC
Date: April , 2025
Key Points:
1. New Technology:
• The FIRE1 Norm is an implantable sensor placed in the inferior vena cava (IVC) to monitor intravascular fluid volume in heart failure (HF) patients.
2. Purpose and Promise:
• It aims to detect early signs of congestion before clinical symptoms appear, potentially enabling earlier interventions and reducing hospital readmissions.
3. Study Details:
• First-in-human study included 50 patients (mean age 65, 86% male).
• Device implantation and signal acquisition were successful in 49 out of 50 patients.
• One patient died before 3-month follow-up (unrelated to the device).
4. Safety and Efficacy:
• After 6 months, the device remained safe with two additional deaths unrelated to the device or procedure.
• Strong correlation between IVC sensor data and CT measurements confirmed its accuracy.
5. Clinical Outcomes:
• NT-proBNP levels decreased significantly.
• 12 patients improved from NYHA class III to class II.
• No significant changes in BMI or 6-minute walk test.
• Notably, there was an 80% reduction in HF events per patient-year.
6. Device Functionality:
• The system includes an implantable sensor, external hardware, belt, and a web platform.
• Patients maintained a 96% median daily adherence, with over 7,400 successful transmissions.
7. Future Improvements:
• A next-generation version is in development, integrating a mobile app and real-time patient feedback, promoting self-management with minimal physician intervention.
8. Conclusion:
• The IVC sensor is safe, feasible, and highly accurate.
• More studies are underway to validate long-term benefits.
